361 related articles for article (PubMed ID: 30832742)
21. Immunotherapy of Sepsis: Blind Alley or Call for Personalized Assessment?
Prucha M; Zazula R; Russwurm S
Arch Immunol Ther Exp (Warsz); 2017 Feb; 65(1):37-49. PubMed ID: 27554587
[TBL] [Abstract][Full Text] [Related]
22. Personalized Therapy: Immunoglobulin Replacement for Antibody Deficiency.
Wasserman RL
Immunol Allergy Clin North Am; 2019 Feb; 39(1):95-111. PubMed ID: 30466775
[TBL] [Abstract][Full Text] [Related]
23. Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial.
Eskandary F; Dürr M; Budde K; Doberer K; Reindl-Schwaighofer R; Waiser J; Wahrmann M; Regele H; Spittler A; Lachmann N; Firbas C; Mühlbacher J; Bond G; Halloran PF; Chong E; Jilma B; Böhmig GA
Trials; 2019 Jan; 20(1):37. PubMed ID: 30635033
[TBL] [Abstract][Full Text] [Related]
24. A randomized controlled phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy of newly diagnosed glioblastoma (GlioVax): study protocol for a randomized controlled trial.
Rapp M; Grauer OM; Kamp M; Sevens N; Zotz N; Sabel M; Sorg RV
Trials; 2018 May; 19(1):293. PubMed ID: 29801515
[TBL] [Abstract][Full Text] [Related]
25. [The therapy of gram-negative septicotoxic diseases with pentaglobin, an immunoglobulin with an elevated IgM content (a prospective, randomized clinical study)].
Schedel I; Dreichhausen U
Anesteziol Reanimatol; 1996; (3):4-9. PubMed ID: 8967617
[TBL] [Abstract][Full Text] [Related]
26. The INIS Study. International Neonatal Immunotherapy Study: non-specific intravenous immunoglobulin therapy for suspected or proven neonatal sepsis: an international, placebo controlled, multicentre randomised trial.
INIS Study Collaborative Group
BMC Pregnancy Childbirth; 2008 Dec; 8():52. PubMed ID: 19063731
[TBL] [Abstract][Full Text] [Related]
27. Treatment with IgM-enriched immunoglobulin in sepsis: a matched case-control analysis.
Martinez JI; Sánchez HF; Velandia JA; Urbina Z; Florián MC; Martínez MA; Giamarellos-Bourboulis EJ; Pino-Pinzón CJ; Ortiz G; Celis E
J Crit Care; 2021 Aug; 64():120-124. PubMed ID: 33872918
[TBL] [Abstract][Full Text] [Related]
28. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D
J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
[TBL] [Abstract][Full Text] [Related]
29. Intravenous immunoglobulins prevent the breakdown of the blood-brain barrier in experimentally induced sepsis.
Esen F; Senturk E; Ozcan PE; Ahishali B; Arican N; Orhan N; Ekizoglu O; Kucuk M; Kaya M
Crit Care Med; 2012 Apr; 40(4):1214-20. PubMed ID: 22202704
[TBL] [Abstract][Full Text] [Related]
30. The use of IgM-enriched immunoglobulin in adult patients with sepsis.
Kakoullis L; Pantzaris ND; Platanaki C; Lagadinou M; Papachristodoulou E; Velissaris D
J Crit Care; 2018 Oct; 47():30-35. PubMed ID: 29886064
[TBL] [Abstract][Full Text] [Related]
31. Success of anti-CD20 monoclonal antibody treatment for severe autoimmune hemolytic anemia caused by warm-reactive immunoglobulin A, immunoglobulin G, and immunoglobulin M autoantibodies in a child: a case report.
Ajmi H; Mabrouk S; Hassayoun S; Regaieg H; Tfifha M; Jalel C; Skouri H; Zouari N; Abroug S
J Med Case Rep; 2017 Nov; 11(1):321. PubMed ID: 29132419
[TBL] [Abstract][Full Text] [Related]
32. Closed Or Open after Source Control Laparotomy for Severe Complicated Intra-Abdominal Sepsis (the COOL trial): study protocol for a randomized controlled trial.
Kirkpatrick AW; Coccolini F; Ansaloni L; Roberts DJ; Tolonen M; McKee JL; Leppaniemi A; Faris P; Doig CJ; Catena F; Fabian T; Jenne CN; Chiara O; Kubes P; Manns B; Kluger Y; Fraga GP; Pereira BM; Diaz JJ; Sugrue M; Moore EE; Ren J; Ball CG; Coimbra R; Balogh ZJ; Abu-Zidan FM; Dixon E; Biffl W; MacLean A; Ball I; Drover J; McBeth PB; Posadas-Calleja JG; Parry NG; Di Saverio S; Ordonez CA; Xiao J; Sartelli M;
World J Emerg Surg; 2018; 13():26. PubMed ID: 29977328
[TBL] [Abstract][Full Text] [Related]
33. Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.
Albrich WC; Harbarth S
Intensive Care Med; 2015 Oct; 41(10):1739-51. PubMed ID: 26194026
[TBL] [Abstract][Full Text] [Related]
34. Comparison of prophylactic use of intravenous immunoglobulin versus Pentaglobin® in pediatric patients after hematopoietic stem cell transplantation.
Azık F; Bayram C; Erkoçoğlu M; Tezer H; Yazal Erdem A; Işık P; Avcı Z; Özbek N; Tavil B; Tunc B
Pediatr Transplant; 2016 Mar; 20(2):276-83. PubMed ID: 26614176
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
[TBL] [Abstract][Full Text] [Related]
36. Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases.
Rello J; van Engelen TSR; Alp E; Calandra T; Cattoir V; Kern WV; Netea MG; Nseir S; Opal SM; van de Veerdonk FL; Wilcox MH; Wiersinga WJ
Clin Microbiol Infect; 2018 Dec; 24(12):1264-1272. PubMed ID: 29581049
[TBL] [Abstract][Full Text] [Related]
37. Immunoglobulin treatment in sepsis--is the answer "no"?
Werdan K
Crit Care Med; 2006 May; 34(5):1542-4. PubMed ID: 16633249
[No Abstract] [Full Text] [Related]
38. Early sepsis treatment with immunoglobulins after cardiac surgery in score-identified high-risk patients.
Pilz G; Kreuzer E; Kääb S; Appel R; Werdan K
Chest; 1994 Jan; 105(1):76-82. PubMed ID: 8275790
[TBL] [Abstract][Full Text] [Related]
39. [The pentaglobin transfusion for the early postpneumonectomy complications' prophylaxis in patients with polyresistant lung tuberculosis].
Agkatsev TV; Mozhokina GN; Penagi SA
Khirurgiia (Mosk); 2012; (5):63-6. PubMed ID: 22810539
[No Abstract] [Full Text] [Related]
40. Adjunctive IgM-enriched immunoglobulin therapy with a personalised dose based on serum IgM-titres versus standard dose in the treatment of septic shock: a randomised controlled trial (IgM-fat trial).
Biagioni E; Tosi M; Berlot G; Castiglione G; Corona A; De Cristofaro MG; Donati A; Feltracco P; Forfori F; Fragranza F; Murino P; Piazza O; Tullo L; Grasselli G; D'Amico R; Girardis M
BMJ Open; 2021 Feb; 11(2):e036616. PubMed ID: 33574139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
